Invasive Cryptococcosis and adalimumab treatment.
Horcajada
Juan P
JP
Peña
Jose L
JL
Martínez-Taboada
Víctor M
VM
Pina
Trinitario
T
Belaustegui
Isabel
I
Cano
María Eliecer
ME
García-Palomo
Daniel
D
Fariñas
M Carmen
MC
D000068879:Adalimumab; D000368:Aged; D000671:Amputation, Surgical; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003453:Cryptococcosis / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D005260:Female; D005385:Fingers / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000473:pathology / Q000601:surgery; D013717:Tenosynovitis / Q000382:microbiology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab